日前，美国生物制药公司吉利德公布Lenacapavir（来那卡帕韦）预防HIV的临床试验结果，显示出100%的有效性。最新公布的结果是一项名为PURPOSE ...

More than three years have passed since federal health officials arrived in central Appalachia to assess an alarming outbreak ...